Developmental effects of inhalation exposure to 2-bromopropane in rats. 2004

Tetsuya Takeuchi, and Hirokazu Okuda, and Heihachiro Arito, and Kasuke Nagano, and Seigo Yamamoto, and Taijiro Matsushima
Japan Bioassay Research Center, Japan Industrial Safety and Health Association, 2445 Hirasawa, Hadano, Kanagawa 257-0015, Japan. ttakeuch@jisha.or.jp

2-Bromopropane (2-BP), known as a reproductive and hematopoietic toxicant in humans, was assessed for developmental toxicity. Sprague-Dawley rats were exposed by inhalation to 2-BP at a concentration of 0 (control), 125, 250, 500, or 1000 ppm for 6 h per day, 7 days per week during 2 weeks of the pre-mating period, during the mating period until copulation and during the period of gestation days 0-19. After parturition, dams were allowed to breast feed their pups until postnatal day 4. 2-BP exposure resulted in no signs of maternal toxicity as assessed by clinical observations and body weight gain. On the other hand, the inhalation exposure to 1000 ppm markedly decreased the number of pups born, although the number of implantations did not decrease. No effect of 2-BP on pups weights or survival until postnatal day 4 was found. It was found that the repeated inhalation exposure of rats to 1000 ppm 2-BP induced fetal lethality during the post-implantation period.

UI MeSH Term Description Entries
D008297 Male Males
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011297 Prenatal Exposure Delayed Effects The consequences of exposing the FETUS in utero to certain factors, such as NUTRITION PHYSIOLOGICAL PHENOMENA; PHYSIOLOGICAL STRESS; DRUGS; RADIATION; and other physical or chemical factors. These consequences are observed later in the offspring after BIRTH. Delayed Effects, Prenatal Exposure,Late Effects, Prenatal Exposure
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D005260 Female Females
D005298 Fertility The capacity to conceive or to induce conception. It may refer to either the male or female. Fecundity,Below Replacement Fertility,Differential Fertility,Fecundability,Fertility Determinants,Fertility Incentives,Fertility Preferences,Fertility, Below Replacement,Marital Fertility,Natural Fertility,Subfecundity,World Fertility Survey,Determinant, Fertility,Determinants, Fertility,Fertility Determinant,Fertility Incentive,Fertility Preference,Fertility Survey, World,Fertility Surveys, World,Fertility, Differential,Fertility, Marital,Fertility, Natural,Preference, Fertility,Preferences, Fertility,Survey, World Fertility,Surveys, World Fertility,World Fertility Surveys
D005865 Gestational Age The age of the conceptus, beginning from the time of FERTILIZATION. In clinical obstetrics, the gestational age is often estimated from the onset of the last MENSTRUATION which is about 2 weeks before OVULATION and fertilization. It is also estimated to begin from fertilization, estrus, coitus, or artificial insemination. Embryologic Age,Fetal Maturity, Chronologic,Chronologic Fetal Maturity,Fetal Age,Maturity, Chronologic Fetal,Age, Embryologic,Age, Fetal,Age, Gestational,Ages, Embryologic,Ages, Fetal,Ages, Gestational,Embryologic Ages,Fetal Ages,Gestational Ages
D006128 Growth Gradual increase in the number, the size, and the complexity of cells of an individual. Growth generally results in increase in ORGAN WEIGHT; BODY WEIGHT; and BODY HEIGHT.
D006842 Hydrocarbons, Brominated Hydrocarbon compounds with one or more HYDROGEN atoms substituted with BROMINE. Brominated Hydrocarbons
D000014 Abnormalities, Drug-Induced Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment. Drug-Induced Abnormalities,Abnormalities, Drug Induced,Abnormality, Drug-Induced,Drug Induced Abnormalities,Drug-Induced Abnormality

Related Publications

Tetsuya Takeuchi, and Hirokazu Okuda, and Heihachiro Arito, and Kasuke Nagano, and Seigo Yamamoto, and Taijiro Matsushima
January 2023, Journal of occupational health,
Tetsuya Takeuchi, and Hirokazu Okuda, and Heihachiro Arito, and Kasuke Nagano, and Seigo Yamamoto, and Taijiro Matsushima
July 1999, Toxicology,
Tetsuya Takeuchi, and Hirokazu Okuda, and Heihachiro Arito, and Kasuke Nagano, and Seigo Yamamoto, and Taijiro Matsushima
December 2008, Toxicological research,
Tetsuya Takeuchi, and Hirokazu Okuda, and Heihachiro Arito, and Kasuke Nagano, and Seigo Yamamoto, and Taijiro Matsushima
March 2017, Journal of applied toxicology : JAT,
Tetsuya Takeuchi, and Hirokazu Okuda, and Heihachiro Arito, and Kasuke Nagano, and Seigo Yamamoto, and Taijiro Matsushima
March 2004, Toxicology,
Tetsuya Takeuchi, and Hirokazu Okuda, and Heihachiro Arito, and Kasuke Nagano, and Seigo Yamamoto, and Taijiro Matsushima
August 2011, Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases,
Tetsuya Takeuchi, and Hirokazu Okuda, and Heihachiro Arito, and Kasuke Nagano, and Seigo Yamamoto, and Taijiro Matsushima
August 1988, Toxicology letters,
Tetsuya Takeuchi, and Hirokazu Okuda, and Heihachiro Arito, and Kasuke Nagano, and Seigo Yamamoto, and Taijiro Matsushima
April 2003, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
Tetsuya Takeuchi, and Hirokazu Okuda, and Heihachiro Arito, and Kasuke Nagano, and Seigo Yamamoto, and Taijiro Matsushima
March 2002, Journal of toxicology and environmental health. Part A,
Tetsuya Takeuchi, and Hirokazu Okuda, and Heihachiro Arito, and Kasuke Nagano, and Seigo Yamamoto, and Taijiro Matsushima
January 1999, Neurotoxicology and teratology,
Copied contents to your clipboard!